Gilead, Merck to distribute AIDS pill
Gilead Sciences Inc. and Merck & Co. Inc. said Friday they have agreed to distribute a new triple-combination AIDS pill in developing countries. The once-daily drug, Atripla, was approved by the FDA last month. Gilead and Merck said they now plan to pursue registration of the product with the health authorities of individual countries.
Tags : science aids pill distribution news
You will be redirected to Gilead, Merck to distribute AIDS pill, in 20 seconds.